Prevalence of rosacea in transgender and gender-diverse populations: a retrospective cohort study
Br J Dermatol
.
2023 Feb 10;188(2):304-306.
doi: 10.1093/bjd/ljac041.
Authors
Jessika Sanz
1
2
3
,
Julia L Gao
4
,
Dana S King
1
,
Anna M Modest
5
6
,
Erica D Dommasch
1
2
6
Affiliations
1
The Fenway Institute, Fenway Health, Boston, MA, USA.
2
Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
3
New York Institute College of Osteopathic Medicine, Jonesboro, AR, USA.
4
George Washington University School of Medicine & Health Sciences, Washington, DC, USA.
5
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA and.
6
Harvard Medical School, Boston, MA, USA.
PMID:
36763873
DOI:
10.1093/bjd/ljac041
No abstract available
MeSH terms
Gender Identity
Humans
Prevalence
Retrospective Studies
Rosacea* / epidemiology
Transgender Persons*
Grants and funding
Beth Israel Deaconess Medical Center